Evoke Pharma (EVOK) Misses Q3 EPS by 45c
Tweet
Share
E-mailGet Alerts EVOK Hot Sheet
Join SI Premium – FREE
Evoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.45). Revenue for the quarter came in at $4.28 million.
For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Texas Community Bancshares (TCBS) Declares $0.06 Quarterly Dividend; 1.4% Yield
- Advasa Holdings lists on Nasdaq under ticker ADBT
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
